Investigational simufilam failed to reduce cognitive or functional decline in Alzheimer's disease patients in the ReThink-ALZ ...
BridgeBio’s Attruby wins approval for transthyretin amyloid cardiomyopathy while the FDA accepts Alnylam’s application for ...
Tau behaves abnormally in the brain in people with Alzheimer’s disease. This latest study points to a reason why.
(Reuters) -Cassava Sciences said it will stop all trials of its Alzheimer's disease drug after it failed a late-stage study, ...
Stay alert with list of early signs and symptoms of dementia that disrupts daily life and may be a symptom of Alzheimer’s or ...
Alzheimer’s is the most common type of dementia. Music therapy can improve mood and cognitive performance in Alzheimer’s ...
Guided by the Alzheimer's Disease Prevention and Preparedness Task Force, California has taken “significant” action and made ...
Alector’s AbbVie-partnered Alzheimer's asset has failed to slow disease progression in a phase 2 study, the latest in a ...
WOLF Wilkes-Barre-Scranton on MSN7h
Alliance for Aging Research advocates for Medicare coverage of early Alzheimer's drugsNovember is National Alzheimer’s Awareness Month.The Alliance for Aging Research is using this month to raise awareness about ...
Americans 65 and older have Alzheimer’s, which is why it’s so important for us to have tips and tricks for keeping them safe ...
Using genetic tools, the scientists then blocked TYK2 in the mice with Alzheimer's. This resulted in a reduction in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback